Muscle Relaxation

3

Review clinical trials related to Muscle Relaxation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effect of Magnesium Sulphate Pretreatment in Pediatric Abdominal Surgery

In this study, the investigators will compare the effect of magnesium sulphate pretreatment on the onset and duration of intense and deep neuromuscular Block of rocuronium versus Cis-Atracurium and on the period of no response to nerve stimulation in children undergoing elective open abdominal surgeries.

Participants needed: 58
Trial details
Phase: Phase 2, Phase 3Age: 2-12Biological sex: AllType: InterventionalSponsor: Assiut UniversityUpdated: Jan 20, 2025Locations: 2
Eligibility criteria

Age group 2-12 years old [+3]

Patients who are beyond the selected age group. [+6]

Status: Recruiting

The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)

The study aims to improve the safety of the electroporation ablation (PFA) procedure by using muscle relaxants to reduce skeletal muscle damage during the procedure. It will also assess myocardial damage to improve the procedure's quality and speed up recovery after the procedure.

Participants needed: 32
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: 4th Military Clinical Hospital with Polyclinic, PolandUpdated: Nov 27, 2024Locations: 1
Eligibility criteria

Patients with requirement for PFA ablation for cardiac indications and ability t...

Patients with allergies to the general anaesthetics used, genetic diseases of th...

Status: Recruiting

Effect of MgSO4 Pretreatment on Muscle Relaxation

In this study, the effect of magnesium sulphate on the onset and duration of intense and moderate cis-atracurium induced neuromuscular blocking and on the period of no response to nerve stimulation will be evaluated in patients who will recieve magnesium sulphate (intervention group) and patients who will not recieve magnesium sulphate (comparator group).

Participants needed: 100
Trial details
Phase: Phase 2, Phase 3Age: 18-60Biological sex: AllType: InterventionalSponsor: Assiut UniversityUpdated: Jul 1, 2024Locations: 1
Eligibility criteria

Age group 18-60 years old [+4]

Patients who are less than 18 years old or more than 60 years old. [+7]